Treatment of ischaemic stroke with prostacyclin.
Author(s) -
Ryszard J. Gryglewski,
Sebastian Nowak,
E Kostka-Trąbka,
J Kuśmiderski,
A. Dembińska-Kieć,
K Bieroń,
M Basista,
Barbara Błaszczyk
Publication year - 1983
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/01.str.14.2.197
Subject(s) - medicine , prostacyclin , hemiparesis , stroke (engine) , anesthesia , cardiology , occlusion , angiography , mechanical engineering , engineering
Ten patients with ischaemic stroke were treated with prostacyclin (2.5-5.0 ng/kg/min i.v. in 6 h courses 4-10 times during 1-2.5 days). In all patients a dramatic regression of hemiplegia, or hemiparesis, or aphasia occurred in the first few hours of prostacyclin infusion. Four to eight weeks later 6 patients left the clinic without neurological deficit; 3 patients had minor residual hemiparesis in upper limbs. In one patient, the occlusion of the contralateral carotid artery led to his death. It is considered that an antagonism may exist between endogenous cerebral prostanoids and prostacyclin and may have been responsible for the beneficial effects of prostacyclin therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom